These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6410489)

  • 1. Development and characteristics of live AIK-C measles virus vaccine: a brief report.
    Makino S
    Rev Infect Dis; 1983; 5(3):504-5. PubMed ID: 6410489
    [No Abstract]   [Full Text] [Related]  

  • 2. Measles vaccines used in Japan.
    Hirayama M
    Rev Infect Dis; 1983; 5(3):495-503. PubMed ID: 6879005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine.
    Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):13-21. PubMed ID: 4476032
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of standard-titer AIK-C measles vaccine in nine-month-old infants.
    Tsai HY; Huang LM; Shih YT; Chen JM; Jiang TM; Tsai CH; Lee CY
    Viral Immunol; 1999; 12(4):343-8. PubMed ID: 10630793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
    Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
    Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vaccination against measles].
    Domorázková E
    Cesk Pediatr; 1977 Dec; 32(12):732-4. PubMed ID: 610938
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy of specific prophylaxis against measles].
    Andzhaparidze OG; Gordienko HM; Sokolova TM; Dorofeev VM
    Vestn Akad Med Nauk SSSR; 1975; (4):27-33. PubMed ID: 1220365
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of a new live measles vaccine derived in chick chorioallantoic membranes.
    Halsey NA; Weiner LB; Meyers MG; Herrmann KL; Hinman A
    J Biol Stand; 1981 Oct; 9(4):507-11. PubMed ID: 7033226
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of live attenuated and further attenuated measles vaccines in rural areas of Iran.
    Naficy K; Saidi S; Nategh R; Mostatab A; Akbarshahy E
    Arch Gesamte Virusforsch; 1967; 22(1):11-22. PubMed ID: 4879874
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined live measles-mumps virus vaccine.
    Weibel RE; Villarejos VM; Hernández G; Stokes J; Buynak EB; Hilleman MR
    Arch Dis Child; 1973 Jul; 48(7):532-6. PubMed ID: 4719108
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
    [No Abstract]   [Full Text] [Related]  

  • 14. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the modification of the live AIK measles vaccine. I. Adaptation of the further attenuated AIK measles virus (the strain AIK-L33) to chick embryo cells.
    Sasaki K
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):1-12. PubMed ID: 4217404
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical reactions and antibody responses of measles-susceptible healthy children to the live measles "AIK-C" vaccine(chick embryo tissue culture type)].
    Okayama T
    Kansenshogaku Zasshi; 1975 Apr; 49(4):150-8. PubMed ID: 811729
    [No Abstract]   [Full Text] [Related]  

  • 17. A field trial of further attenuated live measles virus vaccines in Japan, 1968.
    Jpn J Med Sci Biol; 1969 Aug; 22(4):191-200. PubMed ID: 4982563
    [No Abstract]   [Full Text] [Related]  

  • 18. Edmonston B and a further attenuated measles vaccine--a placebo controlled double blind comparison.
    Miller G; Gale J; Villarejos V; James W; Arteaga CG; Casey H; Henderson DA
    Am J Public Health Nations Health; 1967 Aug; 57(8):1333-40. PubMed ID: 4860064
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles vaccination.
    Norrby EC
    Bull Pan Am Health Organ; 1976; 10(3):196-7. PubMed ID: 1000095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months.
    Tidjani O; Grunitsky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
    Lancet; 1989 Dec; 2(8676):1357-60. PubMed ID: 2574304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.